Compounded versions of semaglutide, the active ingredient in approved diabetes ... Scott Brunner, CEO of the Alliance for ...

With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, ...

Novo Nordisk’s CEO has alerted healthcare professionals about the growing risks associated with compounded semaglutide, a ...

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

Compounded versions of semaglutide, the active ingredient ... Scott Brunner, CEO of the Alliance for Pharmacy Compounding, a group representing pharmacies that make compounded drugs, noted in ...

Compounded drugs are made by pharmacies or manufacturers other than the companies that make FDA-approved versions of the medicines, and they typically are allowed when drugs are in shortage.